Black Rock Inc. Cytokinetics Inc Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding CYTK
# of Institutions
375Shares Held
129MCall Options Held
3.62MPut Options Held
1.14M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$1.04 Billion0.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$707 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.83MShares$462 Million0.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$376 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.65MShares$215 Million4.28% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.55B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...